[SGMO] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[SGMO] Sangamo Therapeutics, Inc.
Announcement Date
06-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 9.83%
YoY- -112.62%
Quarter Report
SGMO's Result
SGMO's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 26,460 28,563 57,763 21,958 23,562 11,812 2,823 45.17%
PBT -53,125 -47,602 -1,271 -27,361 -12,843 -12,354 -18,968 18.71%
Tax 30 86 237 -54 0 0 -3 -
NP -53,155 -47,688 -1,550 -27,307 -12,843 -12,354 -18,965 18.73%
Tax Rate - - - - - - - -
Total Cost 79,615 76,251 59,313 49,265 36,405 24,166 21,788 24.09%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -200.89 -166.96 -2.68 -124.36 -54.51 -104.59 -671.80 -18.21%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -0.34 -0.33 -0.01 -0.24 -0.13 -0.15 -0.27 3.91%
EPS Diluted -0.34 -0.33 -0.01 -0.24 -0.13 -0.15 -0.27 3.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.